Terms: = Pancreatic cancer AND NFATC2, ENSG00000101096, 4773, Q13469, NFATP, NFAT1, KIAA0611
15 results:
1. Effect of nfatc2- and Sp1-mediated TNFalpha Regulation on the Proliferation and Migration Behavior of pancreatic cancer Cells.
Malsy M; Graf B; Bruendl E; Maier-Stocker C; Bundscherer A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):706-711. PubMed ID: 38035702
[TBL] [Abstract] [Full Text] [Related]
2. Over-expression of cFos by the Transcription Factors nfatc2 and Sp1 in pancreatic cancer Cells.
Malsy M; Graf B; Bruendl E; Maier-Stocker C; Bundscherer A
Anticancer Res; 2023 Nov; 43(11):4897-4904. PubMed ID: 37909980
[TBL] [Abstract] [Full Text] [Related]
3. Oncogenic Role of the nfatc2/NEDD4/FBP1 Axis in Cholangiocarcinoma.
Zhao W; Zhao J; Li K; Hu Y; Yang D; Tan B; Shi J
Lab Invest; 2023 Sep; 103(9):100193. PubMed ID: 37285922
[TBL] [Abstract] [Full Text] [Related]
4. A novel FBW7/nfat1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression.
Liu W; Ren D; Xiong W; Jin X; Zhu L
J Exp Clin Cancer Res; 2022 Jan; 41(1):38. PubMed ID: 35081978
[TBL] [Abstract] [Full Text] [Related]
5. The Effects of Analgesics and Local Anesthetics on Gene Transcription Mediated by nfatc2 and Sp1 in pancreatic Carcinoma.
Malsy M; Graf B; Bundscherer A
Anticancer Res; 2019 Sep; 39(9):4721-4728. PubMed ID: 31519571
[TBL] [Abstract] [Full Text] [Related]
6. The active role of the transcription factor Sp1 in nfatc2-mediated gene regulation in pancreatic cancer.
Malsy M; Graf B; Almstedt K
BMC Biochem; 2019 Jan; 20(1):2. PubMed ID: 30696421
[TBL] [Abstract] [Full Text] [Related]
7. Genetic variation determines VEGF-A plasma levels in cancer patients.
Innocenti F; Jiang C; Sibley AB; Etheridge AS; Hatch AJ; Denning S; Niedzwiecki D; Shterev ID; Lin J; Furukawa Y; Kubo M; Kindler HL; Auman JT; Venook AP; Hurwitz HI; McLeod HL; Ratain MJ; Gordan R; Nixon AB; Owzar K
Sci Rep; 2018 Nov; 8(1):16332. PubMed ID: 30397360
[TBL] [Abstract] [Full Text] [Related]
8. Compensation Claims for Sub-substandard Care of Patients with Gastroentero-pancreatic Neuroendocrine Tumors: A Nationwide Descriptive Study of Cases Between 2005-2016 in Norway.
Desserud KF; Bukholm I; Søreide JA
Anticancer Res; 2017 Oct; 37(10):5667-5671. PubMed ID: 28982884
[TBL] [Abstract] [Full Text] [Related]
9. Interaction between nfatc2 and the transcription factor Sp1 in pancreatic carcinoma cells PaTu 8988t.
Malsy M; Graf B; Almstedt K
BMC Mol Biol; 2017 Aug; 18(1):20. PubMed ID: 28774282
[TBL] [Abstract] [Full Text] [Related]
10. Randomized trial comparing a side-port needle and standard needle for EUS-guided histology of pancreatic lesions.
Ishiwatari H; Hayashi T; Kawakami H; Isayama H; Hisai H; Itoi T; Ono M; Kawakubo K; Yamamoto N; Tanaka M; Itokawa F; Oshiro H; Sonoda T; Hasegawa T;
Gastrointest Endosc; 2016 Oct; 84(4):670-8. PubMed ID: 26995688
[TBL] [Abstract] [Full Text] [Related]
11. GSK-3β Governs Inflammation-Induced nfatc2 Signaling Hubs to Promote pancreatic cancer Progression.
Baumgart S; Chen NM; Zhang JS; Billadeau DD; Gaisina IN; Kozikowski AP; Singh SK; Fink D; Ströbel P; Klindt C; Zhang L; Bamlet WR; Koenig A; Hessmann E; Gress TM; Ellenrieder V; Neesse A
Mol Cancer Ther; 2016 Mar; 15(3):491-502. PubMed ID: 26823495
[TBL] [Abstract] [Full Text] [Related]
12. c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.
Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Häsler R; Rosenstiel P; Hauser C; Egberts JH; Trauzold A; Schneider G; Sipos B; Zeissig S; Schreiber S; Schäfer H; Arlt A
Cell Death Dis; 2014 Oct; 5(10):e1455. PubMed ID: 25299780
[TBL] [Abstract] [Full Text] [Related]
13. WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.
Griesmann H; Ripka S; Pralle M; Ellenrieder V; Baumgart S; Buchholz M; Pilarsky C; Aust D; Gress TM; Michl P
Neoplasia; 2013 Jan; 15(1):11-22. PubMed ID: 23359789
[TBL] [Abstract] [Full Text] [Related]
14. Restricted heterochromatin formation links nfatc2 repressor activity with growth promotion in pancreatic cancer.
Baumgart S; Glesel E; Singh G; Chen NM; Reutlinger K; Zhang J; Billadeau DD; Fernandez-Zapico ME; Gress TM; Singh SK; Ellenrieder V
Gastroenterology; 2012 Feb; 142(2):388-98.e1-7. PubMed ID: 22079596
[TBL] [Abstract] [Full Text] [Related]
15. Disruption of a nuclear nfatc2 protein stabilization loop confers breast and pancreatic cancer growth suppression by zoledronic acid.
Singh SK; Baumgart S; Singh G; König AO; Reutlinger K; Hofbauer LC; Barth P; Gress TM; Lomberk G; Urrutia R; Fernandez-Zapico ME; Ellenrieder V
J Biol Chem; 2011 Aug; 286(33):28761-28771. PubMed ID: 21628454
[TBL] [Abstract] [Full Text] [Related]
